Related Experiment Video
Updated: Mar 30, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Proteostasis in pediatric pulmonary pathology
Silke Meiners1, Korbinian Ballweg2
1Comprehensive Pneumology Center (CPC), Member of the German Center for Lung Research (DZL), University Hospital, Ludwig-Maximilians-Universität, Asklepios Klinik Gauting und Helmholtz Zentrum München, Max-Lebsche-Platz 31, 81377, Munich, Germany. silke.meiners@helmholtz-muenchen.de.
Insights
Proteostasis, the regulation of cellular proteins, is crucial for lung health. Its disruption is linked to chronic lung diseases in both children and adults, offering new therapeutic targets.
Area of Science:
- Cellular Biology
- Pulmonary Medicine
- Molecular Biology
Background:
- Proteostasis maintains cellular health by controlling protein synthesis, folding, and degradation.
- Dysregulation of proteostasis is increasingly recognized as a key factor in chronic lung diseases.
Purpose of the Study:
- To introduce the concept of proteostasis.
- To review the evidence linking proteostasis dysregulation to chronic lung diseases in pediatric and adult populations.
Main Methods:
- Literature review of proteostasis pathways.
- Analysis of existing evidence on proteostasis in lung disease pathogenesis.
Main Results:
- Impaired proteostasis is implicated in both adult and pediatric chronic lung diseases.
- This includes sporadic conditions and hereditary disorders like cystic fibrosis and alpha-1 antitrypsin deficiency.
Conclusions:
- Understanding proteostasis pathways provides novel therapeutic strategies for chronic lung diseases.
- Targeting proteostasis may offer new treatments for lung conditions in young and adult patients.
Abstract:
Protein homeostasis describes the tight supervision of protein synthesis, correct protein maturation and folding, as well as the timely disposal of unwanted and damaged proteins by the ubiquitin-proteasome pathway or the lysosome-autophagy route. The cellular processes involved in preservation of protein homeostasis are collectively called proteostasis. Dysregulation of proteostasis is an emerging common pathomechanism for chronic lung diseases in the adult and aged patient. There is also rising evidence that impairment of protein homeostasis contributes to early sporadic disease onset in pediatric lung diseases beyond the well-known hereditary proteostasis disorders such as cystic fibrosis and alpha-1 antitrypsin (AAT) deficiency. Identifying the pathways that contribute to impaired proteostasis will provide new avenues for therapeutic interference with the pathogenesis of chronic lung diseases in the young and adult. Here, we introduce the concept of proteostasis and summarize available evidence on dysregulation of proteostasis pathways in pediatric and adult chronic lung diseases.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pulmonary Cycle: Exhalation
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

